Subscribe to our Newsletters !!

    Japan supercomputer shows multiplying masks offers little assistance forestalling viral spread

    Japanese supercomputer simulations revealed that wearing two masks gave limited benefit in blocking viral spread compared with a single properly fitted mask. The findings in part contradict recent recommendations from the U.S. Centers of Disease Control and Prevention (CDC) that two masks were better than one at reducing a person’s vulnerability to the coronavirus. Using

    FDA issues emergency use approval for T-Detect COVID Test

    Now, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for its T-Detect COVID Exam developed by Adaptive Biotechnologies. The T-Detect COVID Evaluation is a next generation sequencing established (NGS) test to assist in identifying people with an adaptive T cell immune response to SARS-CoV-2, indicating recent or prior infection with SARS-CoV-2.

    Natco Pharma rises after USFDA gesture for cancer treatment drug

    Natco Pharma jumped 6.2% to Rs 884.35 after the company received final approval for everolimus tablets in the US market. Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has received final approval for its abbreviated new drug application (ANDA) for everolimus tablets (a generic version of Afinitor) from the US Food and

    Pathios Therapeutics boosted by award of significant Innovate UK funding

    OXFORD, UK – 8 March 2021 – Life Science Newswire – Pathios Therapeutics Limited (“Pathios”), an innovative biotech company focused on the development of first-in-class therapies for cancer, today announced that it has been awarded £350K (approximately US$475K) in the form a Smart Grant from Innovate UK, the UK Government’s innovation agency, to accelerate their

    Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index

    Global life sciences leader Cytiva, along with the Financial Times’ research arm Longitude, have compiled a global index, ranking the ability of the biopharma industry to respond to five major challenges; in supply chain, talent, research and development, manufacturing, and government policy and regulation. Respondents answered questions on a scale of 1 to 10 in

    108Labs Launches Colostrupedics™ Whole-Human Infant Formula with Secretory Antibodies

    Research Triangle Park, NC – March 8, 2021 – Life Science Newswire – Today, 108Labs announces the discovery of novel secretory antibody biosynthesis in the development of Colostrupedics™ whole-human infant formula, the first animal-free infant formula exclusively comprising cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies.

    Completely immunized individuals can gather without masks inside, should in any case avoid travel, says US

    People who have been vaccinated against COVID-19 can fulfill without masks inside in small groups with others that have been inoculated but should prevent non-essential traveling and continue to wear face-coverings in public, the Biden administration said on Monday. In a long-awaited update of its guidance for behaviors to prevent the spread of the coronavirus,